Sinovac Biotech Ltd. SVA was a big mover last session, as the company saw its shares rise above 8% on the day. The move came on solid volume with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $5.13–$5.70 in the past one-month time frame.
In the last 30 days, the company has seen no estimate revision and the Zacks Consensus Estimate also remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Sinovac Biotech currently has a Zacks Rank #4 (Sell), while its Earnings ESP is 0.00%.
A better-ranked bio-medical/gene stock is Achillion Pharmaceuticals, Inc. ACHN, which sports a Zacks Rank#1 (Strong Buy).
Is SVA going up? Or down? Predict to see what others think: Up or Down
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
ACHILLION PHARM (ACHN): Free Stock Analysis Report
SINOVAC BIOTECH (SVA): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research